CLDN2 and breast carcinoma: In our breast cancer cohort (n = 86) (Table 1), CLDN2 mRNA transcripts were significantly and positively associated with miR-30a levels in cancerous tissues (Pearson correlation coefficient, 0.375; P = 0.0004) (Figure 6A).